KR102679310B1 - Low-viscosity cosmetic composition containing ceramide - Google Patents
Low-viscosity cosmetic composition containing ceramide Download PDFInfo
- Publication number
- KR102679310B1 KR102679310B1 KR1020210170501A KR20210170501A KR102679310B1 KR 102679310 B1 KR102679310 B1 KR 102679310B1 KR 1020210170501 A KR1020210170501 A KR 1020210170501A KR 20210170501 A KR20210170501 A KR 20210170501A KR 102679310 B1 KR102679310 B1 KR 102679310B1
- Authority
- KR
- South Korea
- Prior art keywords
- ceramide
- cosmetic composition
- change
- weight
- vesicle
- Prior art date
Links
- 229940106189 ceramide Drugs 0.000 title claims abstract description 51
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 title claims abstract description 50
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 title claims abstract description 50
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 title claims abstract description 50
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 239000002537 cosmetic Substances 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 239000002562 thickening agent Substances 0.000 claims abstract description 9
- 238000009472 formulation Methods 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 6
- 230000008569 process Effects 0.000 claims abstract description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- -1 fatty acid ester Chemical class 0.000 claims description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- 239000002738 chelating agent Substances 0.000 claims description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 4
- 239000003349 gelling agent Substances 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 150000005846 sugar alcohols Polymers 0.000 claims description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 claims description 3
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 3
- VQENOYXMFIFHCY-UHFFFAOYSA-N Monoglyceride citrate Chemical group OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O VQENOYXMFIFHCY-UHFFFAOYSA-N 0.000 claims description 3
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical group [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 3
- 229940100539 dibutyl adipate Drugs 0.000 claims description 3
- 229940049918 linoleate Drugs 0.000 claims description 3
- 229940049964 oleate Drugs 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- 229940100460 peg-100 stearate Drugs 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 230000008859 change Effects 0.000 description 58
- 230000000052 comparative effect Effects 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 14
- 150000002632 lipids Chemical class 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- 230000007774 longterm Effects 0.000 description 4
- 230000008591 skin barrier function Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical group CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 2
- 229940033329 phytosphingosine Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000013441 quality evaluation Methods 0.000 description 2
- 230000037384 skin absorption Effects 0.000 description 2
- 231100000274 skin absorption Toxicity 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 낮은 점도를 가짐에도 고함량 포함된 세라마이드가 석출되지 않는 안정성이 탁월하며, 가벼운 제형을 선호하는 소비자들이 거부감없이 사용할 수 있는 세라마이드를 포함하고 있는 저점도 화장료 조성물에 관한 것이다.
본 발명의 화장료 조성물은 전체 중량을 기준으로 세라마이드 담지력을 가진 베지클 0.1∼0.5 중량%을 포함하고, 점증제를 0.4∼0.6 중량%를 포함하고, 점도가 3,500 cps 미만이며, 50℃ 이하의 중저온 공정으로 제조된 것을 특징으로 한다.The present invention relates to a low-viscosity cosmetic composition containing ceramide that has excellent stability without precipitating high amounts of ceramide even though it has a low viscosity, and can be used without objection by consumers who prefer a light formulation.
The cosmetic composition of the present invention contains 0.1 to 0.5% by weight of a vesicle with ceramide carrying capacity, 0.4 to 0.6% by weight of a thickener, based on the total weight, has a viscosity of less than 3,500 cps, and has a temperature of 50°C or lower. It is characterized by being manufactured through a medium-low temperature process.
Description
본 발명은 저점도 화장료 조성물에 관한 것으로, 보다 상세하게는, 낮은 점도를 가짐에도 고함량 포함된 세라마이드가 석출되지 않는 안정한 상태를 유지하여 안정성이 탁월한, 세라마이드를 포함하고 있는 저점도 화장료 조성물에 관한 것이다.The present invention relates to a low-viscosity cosmetic composition, and more specifically, to a low-viscosity cosmetic composition containing ceramide, which has excellent stability by maintaining a stable state in which a high content of ceramide does not precipitate even though it has a low viscosity. will be.
세라마이드는 피부 세포 가운데 표피 각질층의 지질막 성분의 하나로 피부 표면에서 손실되는 수분을 방어하고 외부로부터 유해 물질의 침투를 막는 역할을 하는 물질로, 스핑고신 또는 파이토스핑고신에 지방산이 연결되어 있는 구조를 가지고 있는 스핑고지질류 중 하나이다. 세라마이드는 피부 각질층을 구성하는 각질 세포간 지질 중 약 40% 이상을 차지하며, 이중층의 세포막 및 피부 지질 막의 구성성분이다. 또한 세라마이드는 각질층의 구조 형성이나 기능을 나타내는 데 필수적인 성분으로서 인체에 존재하는 세라마이드는 극성 정도에 따라 다양한 종류로 구분된다.Ceramide is one of the lipid membrane components of the stratum corneum of the epidermis among skin cells. It is a substance that protects against moisture loss from the skin surface and prevents the penetration of harmful substances from the outside. It is a sphingosine that has a structure in which a fatty acid is linked to sphingosine or phytosphingosine. It is one of the high lipids. Ceramide accounts for more than 40% of the interstitial lipids that make up the stratum corneum of the skin and is a component of the double-layer cell membrane and skin lipid membrane. Additionally, ceramide is an essential ingredient in the formation and function of the stratum corneum, and ceramides present in the human body are classified into various types depending on the degree of polarity.
이와 같은 세라마이드는 피부장벽의 중요한 요소로 수분의 증발을 억제하는 지질 장벽의 역할과 각질층의 정연한 구조를 유지하게 하는 기능을 가지고 있으며, 생체친화적이고 매우 뛰어난 보습 효능을 가지고 있고, 특히 아토피 증상을 포함한 피부 건선 등 피부 장벽 기능 이상 병증에 대하여 고함량 순수 세라이미드를 적용하면 피부 장벽 기능 회복에 도움을 줄 수 있는 것으로 알려져 있으나 실제 제품화하는 과정에서 충분한 양의 순수 세라마이드를 적용할 수 없는 기술적 한계는 순수 세라마이드가 물과 오일 모두에 난용성이라는 성질에 기인하며, 이와 같은 세라마이드의 물리 화학적 성질로 인해 화장품의 사용성, 투명도, 제형 안정성을 확보하기가 어려워 화장품 제형에 적용하는데 한계가 있다.Such ceramide is an important element of the skin barrier. It functions as a lipid barrier to suppress evaporation of moisture and maintains the orderly structure of the stratum corneum. It is biocompatible and has an excellent moisturizing effect, and is especially effective in treating atopic dermatitis symptoms. It is known that applying high-content pure ceramide to skin barrier dysfunction conditions such as skin psoriasis can help restore skin barrier function. However, the technical limitation of not being able to apply a sufficient amount of pure ceramide during the actual commercialization process is pure ceramide. This is due to the fact that ceramide is poorly soluble in both water and oil, and due to the physical and chemical properties of ceramide, it is difficult to ensure the usability, transparency, and formulation stability of cosmetics, so there is a limit to its application in cosmetic formulations.
세라마이드를 화장료에 적용한 기술을 살펴보면, 고함량의 난용성 물질 담지력을 포함하는 화장료용 비이클을 포함하는 화장료용 조성물(특허등록 제10-1985277호)은 지방산 에스터를 포함하는 쉘에 세라마이드를 담지하는 무수타입 베지클을 제조하여 제조된 화장료용 조성물인데, 상기 특허에 제시된 제형 예는 90℃의 고온에서 제조되는 문제가 있다.Looking at the technology of applying ceramide to cosmetics, the cosmetic composition containing a cosmetic vehicle containing a high content of poorly soluble substances (Patent Registration No. 10-1985277) is a composition that supports ceramide in a shell containing fatty acid ester. It is a cosmetic composition manufactured by manufacturing an anhydrous type vesicle, but the formulation example presented in the above patent has the problem of being manufactured at a high temperature of 90°C.
또, 세라마이드를 나노 에멀젼화하여 사용하는 방법(특허등록 제10-1529480호)이 시도되었으나, 화장품 내에 안정적으로 첨가할 수 있는 세라마이드의 양이 적고, 에멀젼화하기 위해 사용되는 계면활성제가 피부에 자극을 주어 피부 트러블을 일으키는 등의 문제가 있다.In addition, a method of using ceramide by nano-emulsifying it (Patent Registration No. 10-1529480) has been attempted, but the amount of ceramide that can be stably added to cosmetics is small, and the surfactant used for emulsifying it can irritate the skin. There are problems such as causing skin problems.
본 발명이 해결하고자 하는 기술과제는, 낮은 점도를 가짐에도 고함량 포함된 세라마이드가 석출되지 않는 안정한 상태를 유지하여 안정성이 탁월하며, 가벼운 제형을 선호하는 소비자들이 거부감없이 사용할 수 있는, 세라마이드를 포함하고 있는 저점도 화장료 조성물을 제공하는데 있다.The technical problem that the present invention aims to solve is a product containing ceramide that has excellent stability by maintaining a stable state in which the high content of ceramide does not precipitate even though it has a low viscosity, and can be used without objection by consumers who prefer a light formulation. The aim is to provide a low viscosity cosmetic composition.
본 발명의 세라마이드를 포함하고 있는 저점도 화장료 조성물은 전체 중량을 기준으로 세라마이드 담지력을 가진 베지클 0.1 ~ 0.5 중량%을 포함하고, 점증제를 0.4 ~ 0.6 중량%를 포함하고, 점도가 3,500cps 미만이며, 50℃ 이하의 중저온 공정으로 제조된 것을 특징으로 한다.The low-viscosity cosmetic composition containing ceramide of the present invention contains 0.1 to 0.5% by weight of vesicles with ceramide carrying capacity, 0.4 to 0.6% by weight of thickener, and has a viscosity of 3,500 cps based on the total weight. It is characterized by being manufactured through a low- to medium-temperature process of 50°C or lower.
바람직하게는, 베지클은 세라마이드, 지방산 에스터, 용제, 겔화제, 겔안정화제를 포함하는 것을 특징으로 하는 화장료 조성물로서, 세라마이드는 베지클 총 중량을 기준으로 30∼50 중량% 포함되며, 지방산 에스터는 글리세릴시트레이트/락테이트/리놀리에이트/올리에이트이며, 용제는 다이프로필렌글라이콜 및 다이부틸아디페이트이며, 겔화제는 소듐다이라우미도글루타미드라이신이며, 겔 안정화제는 글리세릴스테아레이트와 하이드로제네이티드레시틴 및 피이지-100스테아레이트이다.Preferably, the vesicle is a cosmetic composition comprising ceramide, fatty acid ester, solvent, gelling agent, and gel stabilizer. Ceramide is contained in an amount of 30 to 50% by weight based on the total weight of the vesicle, and fatty acid ester is glyceryl citrate/lactate/linoleate/oleate, the solvent is dipropylene glycol and dibutyl adipate, the gelling agent is sodium dilaumidoglutamide lysine, and the gel stabilizer is glyceryl stear. These are lecithin, hydrogenated lecithin, and PEG-100 stearate.
본 발명의 화장료 조성물은 세라마이드를 고함량 포함한 젤 또는 토너 형태로 제공되는데, 화장료 조성물에는 세라마이드를 고함량 포함한 베지클, 베지클을 안정화시킬 수 있는 점증제, 기타 보존제, 다가 알코올, 킬레이트제 등을 포함한 것으로, 난용성 물질인 세라마이드를 50℃ 이하의 중저온 공정을 거치고 낮은 점도를 가졌음에도 안정한 상태를 유지하게 된다. 이와 같은 화장료 조성물은 가혹조건 보관 실험에서도 세라마이드가 석출되지 않는 안정한 상태를 유지하기 때문에 안정성이 탁월하며, 세라마이드를 고함량 포함하고 있는 저점도 화장료 조성물을 제조할 수 있어서 가벼운 제형을 선호하는 소비자들이 거부감없이 사용할 수 있는 효과가 있다.The cosmetic composition of the present invention is provided in the form of a gel or toner containing a high content of ceramide. The cosmetic composition contains a vesicle containing a high content of ceramide, a thickener capable of stabilizing the vesicle, other preservatives, polyhydric alcohol, chelating agent, etc. It contains ceramide, a poorly soluble substance, and maintains a stable state even though it has a low viscosity after undergoing a low-to-medium temperature process below 50℃. This type of cosmetic composition has excellent stability because it maintains a stable state in which ceramide does not precipitate even in storage tests under harsh conditions, and it is possible to manufacture a low-viscosity cosmetic composition containing a high content of ceramide, which can be rejected by consumers who prefer light formulations. It has an effect that can be used without it.
도 1은 실시예 1의 안정성 시험을 6개월간 실시한 화장료 조성물을 촬영한 것으로, 좌측부터 가속시험(50℃), 장기보존시험(25℃), 가혹시험(5℃), 가혹시험(-5∼50℃ 온도순환)을 실시하고 난 후의 사진이다Figure 1 is a photograph of the cosmetic composition that was subjected to the stability test of Example 1 for 6 months. From the left, acceleration test (50℃), long-term storage test (25℃), severe test (5℃), and severe test (-5∼ This is a photo after 50℃ temperature cycling.
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 세라마이드를 고함량 포함하고 있는 저점도 화장료 조성물은, 화장료 조성물 총 중량에 대하여 베지클 0.1∼0.5 중량%, 베지클을 안정화시킬 수 있는 점증제 0.4∼0.6 중량%, 기타 보존제, 다가 알코올, 킬레이트제를 포함하며, 화장료 조성물 내 세라마이드는 베지클 총 중량에 대하여 30∼50중량%를 포함한 것을 특징으로 한다.The low-viscosity cosmetic composition containing a high content of ceramide of the present invention contains 0.1 to 0.5% by weight of vesicles, 0.4 to 0.6% by weight of a thickener capable of stabilizing the vesicles, other preservatives, and polyhydric alcohols, based on the total weight of the cosmetic composition. , and a chelating agent, and the ceramide in the cosmetic composition is characterized in that it contains 30 to 50% by weight based on the total weight of the vesicle.
본 발명의 세라마이드 담지력을 가진 베지클은 선행연구(특허등록 제10-1985277호)에서 개발한 것으로, 지방산 에스터를 포함하는 쉘을 포함하는 고함량의 난용성 물질 담지력을 포함하는 화장료용 베지클이다. 세라마이드 담지력을 가진 베지클은 화장료 조성물 총 중량에 대하여 0.1∼0.5 중량%가 포함된다. 0.1 중량% 미만이면 세라마이드를 고함량 포함한다는 본 발명의 목적에 부합하지 않고, 5 중량%를 초과하면 화장료 조성물에 잘 혼합되지 않아서 효과의 균일성을 확보하기가 어렵다.The vesicle with ceramide carrying capacity of the present invention was developed in prior research (Patent Registration No. 10-1985277), and is a cosmetic vegetable containing a shell containing fatty acid ester and containing a high content of poorly soluble substances. It's big. Vesicles with ceramide carrying capacity are included in an amount of 0.1 to 0.5% by weight based on the total weight of the cosmetic composition. If it is less than 0.1% by weight, it does not meet the purpose of the present invention of containing a high content of ceramide, and if it exceeds 5% by weight, it is difficult to ensure uniformity of effect because it does not mix well in the cosmetic composition.
본 발명의 세라마이드는 스핑고신 또는 파이토스핑고신에 지방산이 연결되어 있는 구조를 가지고 있는 스핑고지질류 중 하나로, 피부 장벽에서 수분의 증발을 억제하는 지질 장벽의 역할과 각질층의 정연한 구조를 유지하게 하는 기능을 가지고 있다. 세라마이드는 베지클 총 중량에 대하여 30∼50 중량%가 포함된다. 30 중량% 미만이면 세라마이드를 고함량 포함한다는 본 발명의 목적에 부합하지 않고, 50 중량%를 초과하면 화장료 조성물 내에서 불안정하여 석출될 가능성이 있다.The ceramide of the present invention is one of the sphingolipids having a structure in which a fatty acid is linked to sphingosine or phytosphingosine, and has the role of a lipid barrier to suppress evaporation of moisture from the skin barrier and the function of maintaining the ordered structure of the stratum corneum. there is. Ceramide is contained in an amount of 30 to 50% by weight based on the total weight of the vesicle. If it is less than 30% by weight, it does not meet the purpose of the present invention of containing a high content of ceramide, and if it exceeds 50% by weight, it is unstable and may precipitate within the cosmetic composition.
본 발명의 점증제는 암모늄아크릴로일다이메틸타우레이트/브이피코폴리머를 사용한다. 점증제는 화장료 조성물 총 중량에 대하여 0.4∼0.6 중량%가 포함된다. 0.4 중량% 미만이면 점도 미달로 인해 세라마이드가 석출될 가능성이 있고, 0.6 중량%를 초과하면 저점도 화장료 조성물을 만들기 적합하지 않다. 이렇게 선택된 점증제로 만든 화장료 조성물의 점도는 3,500 cps 미만인 것이 바람직하다The thickener of the present invention uses ammonium acryloyldimethyl taurate/VP copolymer. The thickener is included in an amount of 0.4 to 0.6% by weight based on the total weight of the cosmetic composition. If it is less than 0.4% by weight, ceramide may precipitate due to insufficient viscosity, and if it exceeds 0.6% by weight, it is not suitable for making a low-viscosity cosmetic composition. The viscosity of the cosmetic composition made with the selected thickener is preferably less than 3,500 cps.
본 발명의 보존제는 화장품을 장기간 보존하기 위하여 첨가하는 것으로, 식품의약품안전처장이 고시한 사용 한도 내에서 업계의 통상적인 지식을 가지고 있는 사람들이 주로 사용하는 적정량을 포함한다.The preservative of the present invention is added to preserve cosmetics for a long period of time, and includes an appropriate amount mainly used by people with ordinary knowledge in the industry within the usage limit notified by the Minister of Food and Drug Safety.
다가 알코올은 피부 보습을 위해 첨가하는 원료로, 제조자가 목표로 하는 화장료 조성물의 보습 정도에 맞춰 적정량 사용하며, 그 한도가 별도로 정해지는 것은 아니다.Polyhydric alcohol is a raw material added to moisturize the skin. It is used in an appropriate amount according to the degree of moisturization of the cosmetic composition aimed by the manufacturer, and the limit is not set separately.
킬레이트제는 화장료 조성물 내 금속이온을 봉쇄하기 위하여 첨가하는 것으로, 업계의 통상적인 지식을 가지고 있는 사람들이 주로 사용하는 적정량을 포함한다.Chelating agents are added to block metal ions in cosmetic compositions, and include an appropriate amount that is mainly used by those with ordinary knowledge in the industry.
한편, 본 발명의 세라마이드를 고함량 포함하고 있는 저점도 화장료 조성물은 스킨로션, 스킨 소프너, 에센스로 구성된 그룹의 화장품 제형으로 사용된다.Meanwhile, the low-viscosity cosmetic composition containing a high content of ceramide of the present invention is used in a group of cosmetic formulations consisting of skin lotion, skin softener, and essence.
이하 하기의 실시예들을 통하여 본 발명을 상세하게 설명한다. 다만 본 발명이 실시예들에 의하여 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through the following examples. However, the present invention is not limited to the examples.
<실험예 1> 세라마이드 담지력을 가진 베지클 제조 <Experimental Example 1> Manufacturing of vesicles with ceramide carrying capacity
선행연구(특허등록 제10-1985277호)의 [표 4] 처방을 일부 변경, 하기 [표 1]에 기재되어 있는 성분에 따른 세라마이드 담지력을 가진 베지클을 제조하였다. 구체적으로 성분 1∼4를 70∼80℃에서 가온 혼합 후 성분 5∼7을 첨가하여 교반하였다. 그 후, 혼합물을 50℃로 냉각하고, 1,000∼1,500bar의 압력으로 Microfluidizer에서 2∼3회 후처리 하였다.By partially changing the prescription in [Table 4] of the previous study (Patent Registration No. 10-1985277), a vesicle with ceramide carrying capacity according to the ingredients listed in [Table 1] below was manufactured. Specifically, components 1 to 4 were heated and mixed at 70 to 80°C, then components 5 to 7 were added and stirred. Afterwards, the mixture was cooled to 50°C and post-treated 2 to 3 times in a Microfluidizer at a pressure of 1,000 to 1,500 bar.
<실험예 2> 화장료 조성물의 제조 <Experimental Example 2> Preparation of cosmetic composition
하기 [표 2]에 기재되어 있는 성분을 이용하여 실시예1, 2와, 비교예1, 2의 화장료 조성물을 제조하였다. 구체적으로 성분 1에 2를 실온에서 분산시키고, 성분 3에 4를 실온에서 분산시킨 다음, 성분 5∼7을 투입하여 45∼50℃에서 가온 혼합 한 다음 30℃로 냉각하고 배출한다. Cosmetic compositions of Examples 1 and 2 and Comparative Examples 1 and 2 were prepared using the ingredients listed in Table 2 below. Specifically, component 1 and component 2 are dispersed at room temperature, component 3 and component 4 are dispersed at room temperature, then components 5 to 7 are added and mixed at 45 to 50°C, then cooled to 30°C and discharged.
(중량%)Example 1
(weight%)
(중량%)Comparative Example 1
(weight%)
(중량%)Comparative Example 2
(weight%)
(중량%)Example 2
(weight%)
<실험예 3> 안정성 시험 <Experimental Example 3> Stability test
상기 실험예 2를 통하여 제조한 실시예 및 비교예들을 이용하여 도 1과 같이 화장품 안정성 시험 가이드라인(식품의약품안전처, 2011. 06.)에 따른 가속시험, 장기보존시험 및 가혹시험을 실시하였다. 실험 직후 화장품과 각 온도별로 6개월간 보관한 화장품을 화장품의 일반시험 항목인 균등성, 향취, 색상, 사용감에 대한 상이함 여부를 관능으로 평가하고 그 결과를 [표 3], [표 4], [표 5], [표 6]에 나타내었다.Using the Examples and Comparative Examples prepared through Experimental Example 2 above, accelerated tests, long-term storage tests, and stress tests were conducted according to the Cosmetic Stability Test Guidelines (Ministry of Food and Drug Safety, June 2011) as shown in Figure 1. . Immediately after the experiment, cosmetics and cosmetics stored for 6 months at each temperature were sensory evaluated for differences in uniformity, odor, color, and feeling of use, which are general test items for cosmetics, and the results were reported in [Table 3], [Table 4], [ It is shown in [Table 5] and [Table 6].
(50℃)accelerated test
(50℃)
(25℃)Long-term preservation test
(25℃)
(5℃)harsh test
(5℃)
(-5~50℃ 온도순환)harsh test
(-5~50℃ temperature circulation)
측정 결과 모든 예시에서 향취나 색상, 사용감에서 별다른 변화점은 발생하지 않았으나, 비교예 1의 경우 모든 조건에서 세라마이드가 상부에 띠 형태로 석출되었으며, 비교예 2의 경우 가혹시험 수행 결과 세라마이드가 파우더 형태로 석출된 것을 확인할 수 있었다.As a result of the measurement, no significant changes occurred in scent, color, or feeling of use in all examples. However, in Comparative Example 1, ceramide precipitated in the form of a band at the top under all conditions, and in Comparative Example 2, as a result of the stress test, ceramide was in the form of powder. It was confirmed that it precipitated.
<실험예 4> 품질 평가 <Experimental Example 4> Quality evaluation
상기 실시예 1을 무작위 성인 20명을 대상으로 화장료 조성물 사용 후 피부 흡수도 / 피부 보습감 / 피부 유분감 / 사용감 / 피부상태 개선 정도 / 품질의 우수성 총 6항목에 대한 5점 평가법으로 품질평가를 진행하였으며, 세부 설문 결과를 [표7]에 나타내었다.After using the cosmetic composition in Example 1 on 20 random adults, the quality was evaluated using a 5-point evaluation method for a total of 6 items: skin absorption / skin moisture / skin oiliness / feeling of use / degree of improvement in skin condition / excellence of quality. , The detailed survey results are shown in [Table 7].
설문결과 전체 평균 3.59점으로 평균 이상의 제품 품질을 가지고 있음을 확인할 수 있었다.As a result of the survey, it was confirmed that the overall average score was 3.59, indicating that the product quality was above average.
Claims (4)
점도가 3,500cps 미만이며, 50℃ 이하의 중저온 공정을 통하여 제조되며,
보존제, 다가 알코올, 킬레이트제를 포함하며,
상기 베지클은 세라마이드, 지방산 에스터, 용제, 겔화제, 겔안정화제를 포함하는 것을 특징으로 하는 화장료 조성물로서,
상기 세라마이드는 베지클 총 중량을 기준으로 30∼50 중량% 포함되며,
상기 지방산 에스터는 글리세릴시트레이트/락테이트/리놀리에이트/올리에이트이며,
상기 용제는 다이프로필렌글라이콜 및 다이부틸아디페이트이며,
상기 겔화제는 소듐다이라우미도글루타미드라이신이며,
상기 겔 안정화제는 글리세릴스테아레이트와 하이드로제네이티드레시틴 및 피이지-100스테아레이트인 것을 특징으로 하는 세라마이드를 포함하고 있는 저점도 화장료 조성물.
It contains 0.1 to 0.5% by weight of a vesicle with ceramide carrying capacity and 0.4 to 0.6% by weight of a thickener that can stabilize the vesicle,
The viscosity is less than 3,500cps, and it is manufactured through a medium-low temperature process below 50℃.
Contains preservatives, polyhydric alcohols, and chelating agents.
The vesicle is a cosmetic composition comprising ceramide, fatty acid ester, solvent, gelling agent, and gel stabilizing agent,
The ceramide is contained in an amount of 30 to 50% by weight based on the total weight of the vesicle,
The fatty acid ester is glyceryl citrate/lactate/linoleate/oleate,
The solvents are dipropylene glycol and dibutyl adipate,
The gelling agent is sodium dilaumidoglutamidrisine,
A low-viscosity cosmetic composition containing ceramide, wherein the gel stabilizer is glyceryl stearate, hydrogenated lecithin, and PEG-100 stearate.
상기 점증제는 암모늄아크릴로일다이메틸타우레이트/브이피코폴리머인 것을 특징으로 하는 화장료 조성물.
According to paragraph 1,
A cosmetic composition, characterized in that the thickener is ammonium acryloyldimethyl taurate/V picopolymer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210170501A KR102679310B1 (en) | 2021-12-02 | 2021-12-02 | Low-viscosity cosmetic composition containing ceramide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210170501A KR102679310B1 (en) | 2021-12-02 | 2021-12-02 | Low-viscosity cosmetic composition containing ceramide |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230082744A KR20230082744A (en) | 2023-06-09 |
KR102679310B1 true KR102679310B1 (en) | 2024-06-28 |
Family
ID=86765190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210170501A KR102679310B1 (en) | 2021-12-02 | 2021-12-02 | Low-viscosity cosmetic composition containing ceramide |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102679310B1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101125922B1 (en) * | 2009-11-19 | 2012-03-21 | (주)아모레퍼시픽 | Cosmetic composition with low viscosity |
KR101529480B1 (en) | 2013-08-23 | 2015-06-17 | 코스맥스 주식회사 | Preparing methods nano emulsion |
KR20150029407A (en) * | 2013-09-10 | 2015-03-18 | 주식회사 엘지생활건강 | O/W type washable cleansing composition having rapid phase-transition property |
WO2016140473A1 (en) * | 2015-03-02 | 2016-09-09 | (주)아모레퍼시픽 | Multilamella nanoliposome which contains skin lipid components, and preparation method therefor |
KR101985277B1 (en) | 2017-10-13 | 2019-06-03 | 김동명 | Vehicle for cosmetic composition having loading capacity of high-content pooly-soluble material and composition for cosmetics comprising the same |
KR102181475B1 (en) * | 2018-11-19 | 2020-11-23 | 주식회사 엘지생활건강 | Composition for stabilizing insoluble ingredient and cosmetic composition containing the same |
-
2021
- 2021-12-02 KR KR1020210170501A patent/KR102679310B1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20230082744A (en) | 2023-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2243472B1 (en) | Freeze-dried agent compound | |
EP2192888B1 (en) | Cosmetic or pharmaceutical composition for topical application | |
KR101838642B1 (en) | Cosmetic composition having excellent moisturizing effect for the skin | |
EP1673068B1 (en) | Cosmetic composition promoting oxygen transport into the skin | |
CN112156033B (en) | Essence containing ultra-small molecule sodium hyaluronate and preparation method thereof | |
KR102052621B1 (en) | Method for manufacture of pseudo-skin mimics forming the same structure as the lamella structure of the stratum comea and cosmetic composition comprising thereof | |
KR20130134532A (en) | Multilayer liquid crystal vesicle for relieving skin irritation and for recovering skin barrier, and cosmetic composition comprising the same | |
KR20120058917A (en) | Gel type cosmetic compositions for spray | |
EP2243469B1 (en) | Freeze-dried form body containing magnesium ascorbyl phosphate | |
DE102018214573A1 (en) | Mild cleaning preparation II | |
CN111568829A (en) | High-content ceramide repair cream and preparation method thereof | |
DE102010037961A1 (en) | Cosmetic composition containing liposomes in which an oxazolidin-2-one compound is encapsulated | |
KR20190001136A (en) | Composition of face-lifting pack for improving skin condition comprising oligopeptides | |
KR102679310B1 (en) | Low-viscosity cosmetic composition containing ceramide | |
KR20100079363A (en) | Composition for mask pack containing hyaluronic acid | |
KR20100100202A (en) | Solubilized formulation containing micelle of intercellular lipid ingredients | |
CN112716823A (en) | High-moisture-retention moisture gel cream and preparation method thereof | |
KR102190166B1 (en) | Composition for improving atopy dermatitis, Atopic dermatitis remedy and Manufacturing method thereof | |
EP3843698B1 (en) | Mild cleaning preparation | |
CN111821219A (en) | Composition with moisturizing effect and application thereof | |
KR101681952B1 (en) | Cosmetic composition for improving skin | |
AU2018204216B2 (en) | Skin mimicking emulsion | |
DE10036051A1 (en) | Cosmetic or dermatological preparations for treating sun-tanning contain chitosan and lecithin to delay vaporization of volatile components | |
EP1551373B1 (en) | Use of molded bodies for external application | |
KR20160055990A (en) | Cosmetic Composition for Cold Storage and Preparation Method of Mask Pack Using the Same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |